Jump to main content
Jump to site search

Issue 44, 2013
Previous Article Next Article

Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Author affiliations

Abstract

Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

Graphical abstract: Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Back to tab navigation

Supplementary files

Article information


Submitted
01 Mar 2013
Accepted
22 Apr 2013
First published
23 Apr 2013

Chem. Commun., 2013,49, 5082-5084
Article type
Communication

Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

J. Mains, D. A. Lamprou, L. McIntosh, I. D. H. Oswald and A. J. Urquhart, Chem. Commun., 2013, 49, 5082 DOI: 10.1039/C3CC41583J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.


Social activity

Search articles by author

Spotlight

Advertisements